EAN News

Household Transmission of SARS-CoV-2 A Systematic Review and Meta-analysis

Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study

The mental health impact of the COVID-19 pandemic on people with and without depressive, anxiety, or obsessive-compulsive disorders: a longitudinal study of three Dutch case-control cohorts

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study

Renin–angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis

Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

Baricitinib plus Remdesivir for Hospitalized Adults with COVID-19

Efficacy of Tocilizumab in Patients Hospitalized with COVID-19

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with COVID-19

A Neutralizing Monoclonal Antibody for Hospitalized Patients with COVID-19

Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine

Happy New Year 2021 from the EAN, the Home of Neurology

For January 2021, we have selected: Matschke et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol 2020; 19:919-929. doi: 10.1016/S1474-4422(20)30308-2.

As a Christmas Special to EAN’s RRFS members, we hosted a series of three Master Classes in the course of December 2020 for free.